2021
DOI: 10.1002/bit.27753
|View full text |Cite
|
Sign up to set email alerts
|

Exploiting heterologous and endogenous CRISPR‐Cas systems for genome editing in the probiotic Clostridium butyricum

Abstract: Clostridium butyricum has been widely used as a probiotic for humans and food animals. However, the mechanisms of beneficial effects of C. butyricum on the host remain poorly understood, largely due to the lack of high-throughput genome engineering tools. Here, we report the exploitation of heterologous Type II CRISPR-Cas9 system and endogenous Type I-B CRISPR-Cas system in probiotic C. butyricum for seamless genome engineering. Although successful genome editing was achieved in C. butyricum when CRISPR-Cas9 s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 36 publications
(23 citation statements)
references
References 49 publications
2
21
0
Order By: Relevance
“…The OD 600 values greater than or equal to 0.1 were considered the growth of C. difficile strain. In the :: cwp66 mutant, 40 mM lactose was added to the BHIS medium to induce the expression of the cwp66 gene ( 35 ).…”
Section: Methodsmentioning
confidence: 99%
“…The OD 600 values greater than or equal to 0.1 were considered the growth of C. difficile strain. In the :: cwp66 mutant, 40 mM lactose was added to the BHIS medium to induce the expression of the cwp66 gene ( 35 ).…”
Section: Methodsmentioning
confidence: 99%
“…However, the heterologous Cas9 generally was poisonous to the cells [76,77]. Therefore, the native CRISPR/Cas system of some thermophiles was developed.…”
Section: Application Of Crispr/cas Genome Editing System In Thermophilesmentioning
confidence: 99%
“…gene-editing technique, the allele-coupled exchange, which achieves gene knockout by bi-directional screening based on the pyrE gene [ 268 ]. Recently, efficient gene editing tools developed in CB using the heterologous Type II CRISPR-Cas9 system and endogenous Type I-B CRISPR-Cas system have also been reported [ 269 ]. This easily applied technology reduces the occurrence of the polarity effect in genetic manipulation for CB and lays the foundation for CB-based therapies.…”
Section: Modified Probiotics and Diseasesmentioning
confidence: 99%